Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid Response

NCT01005342 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2009-10-30

No results posted yet for this study

Summary

The aim of this study is to

* Measure the effect on gene expression in leukocytes from a meal rich in oat bran
* Investigate the postprandial glucose, insulin and triglyceride responses after intake of meals containing fiber from different sources (oat, rye and sugar beet fiber) or a meal containing a mixture of these three fibers

Conditions

Interventions

OTHER

Oat bran

82 g oat bran was added to 250 ml blackcurrant beverage with pulp to give 5 g soluble fiber (12.6 g total fiber).

OTHER

Spray-dried oat drink

62 g spray-dried oat drink was added to 250 ml blackcurrant beverage with pulp to give 2.7 g soluble fiber (3.3 g total fiber).

OTHER

Rye bran

31 g rye bran was added to 250 ml blackcurrant beverage with pulp to give 1.7 g soluble fiber (12 g total fiber).

OTHER

Sugar beet fiber

19 g sugar beet fiber was added to 250 ml blackcurrant beverage with pulp to give 5 g soluble fiber (12 g total fiber).

OTHER

Mixture of fiber

38 g spray-dried oat drink, 30 g rye bran and 6 g sugar beet fiber were added to 250 ml blackcurrant beverage with pulp to give 5 g soluble fiber (18 g total fiber).

OTHER

Control

No fiber was added to control meal (250 g black-currant beverage)

Sponsors & Collaborators

  • Vinnova

    collaborator OTHER_GOV
  • Oatly AB

    collaborator UNKNOWN
  • Lantmannen Food R&D

    collaborator UNKNOWN
  • Danisco Sugar AB/Fibrex

    collaborator UNKNOWN
  • Lund University

    lead OTHER

Principal Investigators

  • Gunilla Önning, Dr. · Lund University

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01005342 on ClinicalTrials.gov